[CTXR] YoY Annual Result on 30-Sep-2020 [#FY]

Stock
[CTXR] Citius Pharmaceuticals, Inc.
Announcement Date
16-Dec-2020
Financial Year
2020
Quarter
30-Sep-2020 [#FY]
Profit Trend
YoY- -13.45%
Quarter Report
CTXR's Result
CTXR's Financial Summary
View:
Show?
Annual Result
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -31,967 -33,065 -23,054 -17,548 -15,562 -12,537 -10,385 20.59%
Tax 576 576 71 126 16 1,284 851 -6.29%
NP -32,543 -33,641 -23,125 -17,674 -15,579 -12,537 -10,385 20.95%
Tax Rate - - - - - - - -
Total Cost 32,543 33,641 23,125 17,674 15,579 12,537 10,385 20.95%
Ratio Analysis
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
EPS -0.22 -0.23 -0.21 -0.45 -0.77 -1.17 -1.89 -30.11%
EPS Diluted -0.22 -0.23 -0.21 -0.45 -0.77 -1.17 -1.89 -30.11%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.